An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
New analysis published in the BMJ reveals the UK gambling industry is mimicking the tactics first used by Big Tobacco decades ...
The Manila Times on MSN2h
People can spread bird flu to their cats, US study suggestsA study published Thursday by the US Centers for Disease Control and Prevention (CDC) suggests that people can transmit bird flu to their domestic cats, with fatal consequences.Both case studies ...
NEW analysis published in the BMJ reveals the UK gambling industry is mimicking the tactics first used by Big Tobacco decades ago to downplay the ...
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, announces the ...
The use of tobacco industry tactics by the gambling and other health harming industries means governments must act to prevent large scale avoidable harm, argue May van Schalkwyk and colleagues When an ...
QR code phishing has emerged as a serious threat. A retrofit variation that uses cryptographic security and can even work ...
Researchers at Imperial College London are leading human trials for the innovative treatmentAn inhalable medicine with the potential to improve lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback